Ted S. Yoho sold INNOVATOR IBD 50 ETF (FFTY) (FFTY)
Ted S. Yoho (R-FL), a U.S. Representative, has disclosed 1 trade in INNOVATOR IBD 50 ETF (FFTY) (FFTY) since 2019, a single sale, worth an estimated $33K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Ted S. Yoho sold $15,001 - $50,000 of INNOVATOR IBD 50 ETF (FFTY) (FFTY) on September 27, 2019. Since that trade, FFTY is up +21.19% against the S&P 500 up +171.55%, an outperformance of -150.36%.
Data updated
Ted S. Yoho's FFTY trades vs the price
FFTY is up +21.19% since Ted S. Yoho sold on September 27, 2019, versus +171.55% for the S&P 500.
Performance since this trade
All Ted S. Yoho FFTY trades
Ted S. Yoho & FFTY trading FAQ
Is it legal for Ted S. Yoho to trade INNOVATOR IBD 50 ETF (FFTY) (FFTY) stock?
Yes. Members of Congress are allowed to trade individual stocks, including INNOVATOR IBD 50 ETF (FFTY) (FFTY), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Ted S. Yoho sell FFTY?
Ted S. Yoho disclosed a sale of $15,001 - $50,000 of INNOVATOR IBD 50 ETF (FFTY) (FFTY) on September 27, 2019, according to public STOCK Act filings.
How has FFTY performed since Ted S. Yoho's trade?
Since Ted S. Yoho sold FFTY on September 27, 2019, the stock is up +21.19%, versus +171.55% for the S&P 500 over the same period, an outperformance of -150.36%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional FFTY trades?
Quantellect tracks every disclosed congressional trade in INNOVATOR IBD 50 ETF (FFTY) (FFTY) on the INNOVATOR IBD 50 ETF (FFTY) congressional trading page, which aggregates filings across all members of Congress.
Ted S. Yoho's FFTY tradesAll congressional filings for INNOVATOR IBD 50 ETF (FFTY)Ted S. Yoho's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.